Month: May 2020

NEW YORK, NY and SAN DIEGO, CA, May 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Aegea Biotechnologies, Inc. ( “Aegea”) ( www.aegeabiotech.com), a biotechnology company focusing on the development and commercialization of next generation nucleic acid clinical diagnostic technologies, announces the issuance of 7 additional key US patents related to its core next generation nucleic acid clinical diagnostic technologies, including applications related to COVID-19 diagnostic testing under the collaboration agreement with Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga”).The collection of recently issued, key US patents include U.S. Patent 10,174,352 entitled METHODS FOR AMPLIFICATION OF NUCLEIC ACIDS ON SOLID SUPPORT, U.S. Patents 10,081,825 and 10,590,453, entitled METHODS FOR AMPLIFICATION OF NUCLEIC ACIDS UTILIZING A CIRCULARIZED...

CHANDLER, Ariz., May 18, 2020 (GLOBE NEWSWIRE) — With the rise of Artificial Intelligence (AI), Machine Learning (ML) and the Internet of Things (IoT), applications are moving to the network edge where data is collected, requiring power-efficient solutions to deliver more computational performance in ever smaller, thermally constrained form factors. Through its Smart Embedded Vision initiative, Microchip Technology Inc. (Nasdaq: MCHP) is meeting the growing need for power-efficient inferencing in edge applications by making it easier for software developers to implement their algorithms in PolarFire® field-programmable gate arrays (FPGAs). As a significant addition to the solutions portfolio in this segment, Microchip’s VectorBlox Accelerator Software Development Kit (SDK) helps developers take advantage of Microchip’s PolarFire...

Soprano Oyj sisäpiiritieto 18.5.2020 klo 15.05Soprano sai maksun koulutusvientisopimuksestaSoprano on saanut 1,2 miljoonan euron suorituksen merkittävän koulutusvientisopimuksen mukaisesti pankkitililleen. Yhtiö tiedotti 21.4.2020 allekirjoittaneensa koulutusvientisopimuksen valtiollisen toimijan kanssa. Sopimuksen mukaisesti ensimmäinen 30 prosentin erä on nyt maksettu ja loput 70 prosenttia maksetaan arviolta joulukuussa 2020.Lisätietoja: Soprano Oyj,Toimitusjohtaja Arto Tenhunen, 0400 413 314, arto.tenhunen@soprano.fiTalousjohtaja Panu Kauppinen, 044 236 3740, panu.kauppinen@soprano.fiSoprano Group – Lifelong Learning for Working Professionals 

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) — Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the Benchmark Company Healthcare House Call Virtual Video 1×1 Investor Conference, June 15-16, 2020.Raj Mehra, Ph.D., Chairman and CEO, will host meetings via conference calls.For additional information about the Benchmark Company Healthcare House Call Virtual Video 1×1 Investor Conference: https://benchmark-healthcare-house-call-virtual.events.issuerdirect.com/About Seelos Therapeutics:Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the...

BOWIE, Md., May 18, 2020 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that Keith Dunleavy, M.D., chief executive officer and chairman of the board of Inovalon, and Jonathan R. Boldt, chief financial officer of Inovalon, will participate in a fireside chat at the SunTrust Robinson Humphrey Virtual Meeting Series, hosted by analyst, Sandy Draper.The fireside chat will take place on Friday, May 22, 2020 at 1:00pm ET.  Investors may access the live and archived audio session by using the following link:https://www.netroadshow.com/conferencing/login?show=cb41fd4e&confId=17667A replay of the event will be available for one week on the Investor Relations section of Inovalon’s website at www.inovalon.com.About InovalonInovalon is a leading...

NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) — Acreage Holdings, Inc. (“Acreage” or the “Company”) (CSE: ACRG.U) (OTCQX: ACRGF) (FSE: 0VZ) today announced the sale of certain non-core assets as part of an update to its overall strategic plan to focus on key, profitable operations. The Company expects this shift in focus will lead to immediate margin improvements and accelerate its pathway to achieve positive pro-forma adjusted EBITDA for the full year 2020.The strategic shift is a direct response to significant changes in capital markets, and in anticipation of continued historic pressure on consumer sentiment and regional and national economic uncertainties. In addition to the sale of some non-core and other under-performing assets, Acreage intends to operate with a more optimized overhead cost structure and corporate team to adapt...

Treatment with SPINRAZA improved or stabilized motor function across patient populations, including young adultsThe longer-term safety profile of SPINRAZA was consistent among a broad spectrum of ages and SMA typesNew data add to the significant body of evidence underscoring the clinically meaningful and sustained benefit of SPINRAZA in toddlers, children and young adults treated for up to six and a half yearsCAMBRIDGE, Mass., May 18, 2020 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced additional data from the SPINRAZA (nusinersen) clinical development program that further demonstrate the sustained efficacy and longer-term safety of SPINRAZA in a broad range of patients with spinal muscular atrophy (SMA). These new data were selected for presentation at the 72nd American Academy of Neurology (AAN) annual meeting and...

SANTA CLARA, Calif., May 18, 2020 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that Gary Dickerson, President and CEO, and Dan Durn, Senior Vice President and CFO, will participate in a virtual fireside chat at the Bernstein Strategic Decisions Conference on Wednesday, May 27 beginning at 11:30 a.m. PT / 2:30 p.m. ET.Additionally, Mr. Durn will participate in virtual fireside chats at the following investor conferences:Needham Virtual Technology and Media Conference on Wednesday, May 20 beginning at 9:15 a.m. PT / 12:15 p.m. ET.Cowen 2020 Virtual Technology, Media and Telecom Conference on Thursday, May 28 beginning at 8:50 a.m. PT / 11:50 a.m. ET.BofA Securities Global Technology Conference on Wednesday, June 3 beginning at 7:00 a.m. PT / 10:00 a.m. ET.A live audio webcast of these sessions will be available on the...

LAKEWOOD, NJ, May 18, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Reliance Global Group, Inc. (OTCQB: RELI) (“RELI” or the “Company”) today announced the appointment of David Lazar as an independent member of the Company’s Board of Directors. As a result, the Board of Directors has increased to 5 members, including 3 independent directors, thereby meeting the independence requirements for a national exchange.Mr. Lazar brings domestic and international experience in operations, accounting, audit preparation, due diligence, capital restructuring, debt financing, and mergers and acquisitions. Mr. Lazar is currently the CEO of both Custodian Ventures LLC & Activist Investing LLC, which specialize in reverse merger and other event-driven opportunities. Ezra Beyman, CEO of Reliance Global Group, stated, “We are...

DUBLIN, Ireland and TREVOSE, Pa., May 18, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced the management team will present at the upcoming Solebury Trout Virtual Global Healthcare Conference Series. Details are as follows:Date/Time: Tuesday, May 26, 2020 at 12:00 p.m. EDTTo access the presentation, please login here: https://78449.themediaframe.com/dataconf/productusers/solebury/mediaframe/38244/indexl.htmlThe Company’s presentation will be webcast live and archived on the “Events & Presentations” page in the Investor section of the Company’s website at www.strongbridgebio.com.About Strongbridge BiopharmaStrongbridge Biopharma is...